Superior Determination of HPV using RNAscope™ In Situ Hybridization

contributed by Bio-Techne | 06/21/2021

HPV has been identified as a causal agent in oropharyngeal squamous cell carcinoma (OPSCC) with the incidence of HPV-related OPSCC increasing dramatically over the last several decades. As patients with HPV-positive OPSCC have a significantly better survival compared to patients with HPV-negative OPSCC, testing for HPV status is critical.

Email*

Choose a password

I have read and understand the Privacy Notice *

Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

I want to stay up to date with the Infectious Diseases field I want to stay up to date with the Pathologist Educator field

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.